
==== Front
Cureus
Cureus
2168-8184
Cureus
2168-8184
Cureus Palo Alto (CA)

10.7759/cureus.66063
Pediatric Surgery
Cardiac/Thoracic/Vascular Surgery
Oncology
Invasive Mucinous Adenocarcinoma in a Newborn With Antenatally Diagnosed Congenital Pulmonary Airway Malformation: A Case Report
Muacevic Alexander
Adler John R
Gopalaswamy Madhura 1
Asif Ferwa 2
Alshammari Abdullah 2
Boyle Mark 32
Buderi Silviu 2
Semple Thomas 4
Zhang Yu Zhi 5
Nicholson Andrew G 5
Jordan Simon 2
1 Cardiothoracic Surgery, Royal Brompton Hospital, London, GBR
2 Thoracic Surgery, Royal Brompton Hospital, London, GBR
3 Surgery and Cancer, Imperial College London, London, GBR
4 Radiology, Royal Brompton Hospital, London, GBR
5 Histopathology, Royal Brompton Hospital, London, GBR
Madhura Gopalaswamy m.gopalaswamy@rbht.nhs.uk
3 8 2024
8 2024
16 8 e660632 8 2024
Copyright © 2024, Gopalaswamy et al.
2024
Gopalaswamy et al.
https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This article is available from https://www.cureus.com/articles/270125-invasive-mucinous-adenocarcinoma-in-a-newborn-with-antenatally-diagnosed-congenital-pulmonary-airway-malformation-a-case-report
Congenital pulmonary airway malformations (CPAMs) are rare multicystic lung lesions typically diagnosed antenatally. We present a case of a term female neonate with antenatally diagnosed CPAM who required pleuro-amniotic shunting at 22 weeks of gestation. The patient was born with a right-sided pneumothorax and severe cardiorespiratory distress, necessitating extracorporeal membrane oxygenation (ECMO). Chest CT confirmed CPAM, revealing multiple cystic lesions in the right middle lobe and a significant contralateral mediastinal shift. On the second day of life, while on ECMO, the patient underwent a right middle lobectomy and an upper lobe anterior segmentectomy via a posterolateral thoracotomy. Post-surgery cardiac CT showed narrowing of the left pulmonary artery, although a perfusion study indicated normal left lung perfusion. Histopathological examination identified CPAM type 1 with invasive mucinous adenocarcinoma (IMA; stage 1: pT1b), featuring low-to-intermediate cellularity and KRAS G12D mutations. The invasive mucinous component measured at least 15 mm but did not invade the visceral pleura. After a gradual weaning process, the patient was successfully extubated and discharged home after 70 days. To our knowledge, this is the first reported case of CPAM type 1 with IMA that underwent pleuro-amniotic shunting in the second trimester.

congenital lung malformations
neonate
lung lobectomy
ecmo
cpam
==== Body
pmcIntroduction

Congenital pulmonary airway malformations (CPAMs) are rare developmental cystic lung lesions characterized by architectural disorganization of the respiratory structures [1]. Large-scale population studies from the UK, Canada, and Hong Kong estimate an incidence of 4 per 10,000 live births [2-5]. Stocker described five major types of CPAMs (Appendix A), each originating from different parts of the bronchial tree. CPAM type 1, the most common, consists of bronchiole-like cysts up to 20 mm in diameter, along with smaller cysts and alveolar parenchyma [6,7].

In approximately one-third of type 1 CPAM cases, proliferation of cytologically bland mucinous cells is observed, with terms such as mucinous cell hyperplasia, mucinous metaplasia, and atypical goblet cell hyperplasia being used to describe these changes [8-10]. These mucinous proliferations can occasionally extend along the alveolar septa into adjacent alveoli, making them difficult to differentiate from invasive mucinous adenocarcinoma (IMA) or mucinous adenocarcinoma in situ (AIS), depending on factors like lesion size, invasion, and multifocality [11]. Molecular analysis of these mucinous cells has revealed various mutations, including KRAS, EGFR, and others, which are similar to those commonly found in de novo mucinous adenocarcinomas in adults [12].

We present a case of IMA in a newborn with antenatally diagnosed CPAM type 1, who had undergone in-utero pleuro-amniotic shunting.

Case presentation

We report a case of antenatally diagnosed CPAM. During antenatal visits in the second trimester, an ultrasound revealed a large solid and cystic lesion in the right hemithorax, leading to a provisional diagnosis of large-mixed CPAM. At 22 weeks of gestation, a fetal pleuro-amniotic shunt was inserted, placing a tube between the fetal thorax and the amniotic cavity to prevent fetal hydrops. The shunt was removed shortly after birth. Obstetric consultation recommended an elective cesarean section at 39 weeks.

The female patient was delivered at Chelsea and Westminster Hospital via elective cesarean section at around 39 weeks, weighing 2,480 grams. Due to cardiovascular and respiratory instabilities during resuscitation, she was immediately intubated, mechanically ventilated with inhaled nitric oxide at 20 ppm, and transferred to the neonatal intensive care unit. A chest X-ray revealed a right-sided pneumothorax (Figure 1), prompting the insertion of two 10 Fr chest drains (in the fourth intercostal space and apically), which were connected separately to underwater seals at -0.8 kPa suction.

Figure 1 Chest X-ray of the newborn on day 1 of life showing a right-sided pneumothorax

A large right tension pneumothorax with cystic lucencies in the collapsed right lung, consistent with the known CPAM. The left lung is partially aerated.

CPAM, congenital pulmonary airway malformation

On the second day of life, due to respiratory and cardiovascular instabilities while on mechanical ventilation, the patient was placed on veno-arterial extracorporeal membrane oxygenation (VA/ECMO). A chest CT revealed a right middle lobe CPAM with a significant contralateral mediastinal shift, which explained the patient’s instability (Figure 2). A simultaneous head CT showed no structural abnormalities, consistent with the earlier bedside transcranial ultrasound.

Figure 2 Chest CT of the newborn showing a right middle lobe CPAM

A large right middle lobe congenital cystic malformation occupies much of the right hemithorax, with a significant contralateral mediastinal shift. A relatively small patent ductus arteriosus is also noted.

CPAM, congenital pulmonary airway malformation

Under VA/ECMO support on the second day of life, a complete resection of the right middle lobe was performed via a right posterolateral thoracotomy. Additionally, a right upper lobe anterior segmentectomy was undertaken due to a persistent air leak observed in the operating theater. Prior to closure, two 10 Fr chest drains were inserted and connected to separate Thopaz systems set at -0.8 kPa suction. Postoperatively, piperacillin/tazobactam and teicoplanin were immediately started and later switched to cefotaxime and gentamicin based on microbiological advice due to rising CRP levels. Gentamicin was discontinued after three days, while cefotaxime was stopped after five days.

Postoperatively, the patient was transferred to the pediatric intensive care unit (PICU) and remained on ECMO/VA support for an additional two days before being decannulated. She was kept intubated for four days, after which she was extubated and placed on high-flow nasal cannula oxygen for four days. She was reintubated due to respiratory deterioration caused by the inspiratory paradoxical motion of the right hemidiaphragm and remained intubated for a total of 39 days. Piperacillin/tazobactam was restarted after reintubation for four days, having been previously stopped due to negative cultures. At one month of age, during the reintubation period, an echocardiogram, cardiac CT, and perfusion study were performed, revealing no abnormal findings except for narrowing of the left pulmonary artery during the perfusion study. However, this narrowing did not limit left pulmonary perfusion. At two months of age, the patient was extubated for the second time and placed on high-flow nasal cannula oxygen, eventually being weaned to room air. Chest drains were removed one at a time after showing no air leak for more than 24 hours and less than 5 ml/kg/hr of output over a 24-hour period.

The pathology report of the resected lesion revealed type 1 CPAM with coexistent mucinous proliferation, interpreted as IMA (pT1b) with free surgical margins (R0). The invasive mucinous component measured at least 15 mm, with no invasion of the visceral pleura. Tumor cellularity was low to intermediate, and tumor content was assessed at 25%. Molecular analysis of the resected lesion identified a KRAS (G12D) mutation. The tumor was negative for EGFR, ALK, BRAF, ERBB2, MET, TP53, CDKN2A, and RB1 genes, consistent with the literature (Figure 3) [13].

Figure 3 Mucinous cell clusters/mucinous adenocarcinoma arising from type 1 congenital pulmonary adenomatoid malformation

(A) Cysts are lined by ciliated respiratory-type epithelium, interspersed with lung parenchyma showing developmental arrest at the late saccular to alveolar stage. (B) The cystic lesion exhibits multifocal involvement by mildly atypical mucinous cells with foveolar-type morphology and a pure lepidic growth pattern.

The patient was discharged after 71 days in the PICU/HDU and eight days of ward-level care. At discharge, she was able to safely take a daily dose of 10 ml of formula milk with no overt signs of discoordination, and her chest X-ray showed a satisfactory, stable post-surgical appearance (Figure 4). She continued to receive the rest of her nutritional requirements through nasogastric tube feeding. Anti-reflux medications and a weaning regimen from sedatives were prescribed for the post-discharge period. The patient was discharged with planned follow-up by cardiology, respiratory, dietetics, speech and language therapy, as well as pediatric oncology, at various intervals to monitor progress. The gyne-oncologist advised that no follow-up was required for the mother, as there was minimal risk of malignant cell seeding from the pleuro-amniotic shunt, with no histological evidence of invasion of the visceral pleura.

Figure 4 Postoperative chest X-ray

The chest deformity at the site of the thoracotomy remains stable in appearance. The lungs are well-aerated, and the cardiomediastinal contours are normal.

Discussion

Although CPAMs are considered rare, they are the most common congenital lung disease, typically detected prenatally between 18 and 20 weeks of gestation [1].

Histopathological examination of the resected right middle lobe in our patient revealed type 1 CPAM with IMA. Type 1 CPAM is the most common type, with roughly one-third of cases showing papillary growth of mucinous cells on the cyst surface [7]. There is significant debate regarding the appropriate terminology for these mucinous cell proliferations and whether they should be classified as neoplastic or nonneoplastic lesions. Some argue against labeling these lesions as malignant or premalignant, citing a lack of malignant behavior if complete resection is achieved [14]. However, a study by Chang et al. demonstrated that recurrence can occur several years after initial surgical resection in their series of 37 patients [15]. Furthermore, mucinous proliferations can spread directly through the alveolar parenchyma adjacent to cystic areas, as shown by Summers et al., who reported contralateral lung metastasis of mucinous adenocarcinoma in an eight-year-old patient with a well-differentiated multifocal lesion following lobectomy [16].

Molecular analysis of the mucinous cells in our study revealed KRAS G12D mutations, which are commonly observed in de novo mucinous adenocarcinomas in adults [17]. This supports the classification of these proliferations as having neoplastic potential. Similar mutations were found in most lesions, as reported by Chang et al., who identified KRAS G12D in 50% of cases and KRAS G12V in 40% of cases, with overall mutations present in 90% of their study [15]. Thus, the molecular findings and the recurrence of these lesions years after initial surgery support using the WHO criteria of AIS and invasive adenocarcinoma for their description and classification [18].

In our case, anatomical resection of the lesion was performed, adhering to the recommended optimal treatment for CPAMs. Nonanatomical resection is associated with a higher incidence of residual disease and recurrence after initial surgery [19]. This approach often makes it challenging to definitively identify the boundary between diseased and normal tissue, particularly given the malignant potential of mucinous cells that can spread through the alveolar parenchyma [15]. A study of 44 CPAM cases with mucinous proliferations found that anatomical resection, such as lobectomy, resulted in better outcomes compared to nonanatomical resection [14].

Our patient experienced severe cardiovascular and respiratory instability from birth, necessitating mechanical ventilation and ECMO support for over two months, with only brief periods of clinical improvement. Clinical outcomes for CPAMs depend on several factors, including prenatal diagnosis of nonimmune hydrops, symptomatic presentation at birth, and the size of the lesion [20].

In utero transmission of maternal cancers to infants is an extremely rare event, with an estimated incidence of 1 case per 500,000 mothers with cancer [21]. The proposed routes of transmission are transplacental hematogenous spread or direct spread during vaginal delivery. Direct spread has been documented in cases of fetal lung cancer transmitted from maternal cervical cancers [22]. Although fetal-to-maternal malignant cell seeding has never been documented, there is a theoretical risk of direct seeding of fetal malignant cells into the mother via pleuro-amniotic shunting. However, histopathological examination of the visceral pleura and pleural fluid in our case revealed no malignant cells, further disproving this theoretical risk.

Conclusions

CPAMs are rare multicystic lung lesions typically diagnosed antenatally. We present a case of a term female neonate with antenatally diagnosed CPAM who required pleuro-amniotic shunting at 22 weeks of gestation and successfully underwent definitive lung resection with ECMO support. To our knowledge, this is the first documented case of CPAM type 1 with IMA associated with pleuro-amniotic shunting in the second trimester. Further research is needed to evaluate the risk of malignant cell seeding through the pleuro-amniotic shunt and the implications for maternal follow-up.

Disclosures

Author Contributions

Appendices

 Appendix A

Table 1 Stocker classification describing the five major types of CPAM

Source: Mehta and Sharma (2024) [23]

CPAM, congenital pulmonary airway malformation

Stocker classification	Origin	Appearance	Prognosis	
Type 0	Trachea or bronchi	Bronchial-type airways with cartilage, smooth muscles, and glands separated by mesenchyme	Incompatible with life	
Type 1	Bronchi	Cysts are usually multiloculated, within one lobe and lined with pseudo-stratified columnar epithelium	Excellent prognosis following resection. Rarely undergoes malignant transformation	
Type 2	Bronchiolar regions	Multiple small cysts with no mass effect	Good prognosis, no malignant potential	
Type 3	Bronchiolar regions	Typically solid versus cystic, usually devoid of pulmonary arteries within the lesion	Good prognosis, no malignant potential	
Type 4	Acinar structures of the lung	Multiloculated, peripheral, thin-walled cysts lined with type 1 or type 2 alveolar cells	Strong association with pleuropulmonary blastomas	

Human subjects: Consent was obtained or waived by all participants in this study.

Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following:

Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work.

Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work.

Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Concept and design:  Mark Boyle, Madhura Gopalaswamy, Abdullah Alshammari, Silviu Buderi, Thomas Semple, Andrew G. Nicholson

Drafting of the manuscript:  Mark Boyle, Madhura Gopalaswamy, Abdullah Alshammari, Thomas Semple, Simon Jordan

Critical review of the manuscript for important intellectual content:  Silviu Buderi, Yu Zhi Zhang, Andrew G. Nicholson, Ferwa Asif

Acquisition, analysis, or interpretation of data:  Yu Zhi Zhang, Simon Jordan, Ferwa Asif
==== Refs
References

1 COllaborative Neonatal Network for the first European CPAM Trial (CONNECT): a study protocol for a randomised controlled trial BMJ Open Kersten CM Hermelijn SM Dossche LW 0 13 2023
2 The increasing incidence of foetal echogenic congenital lung malformations: an observational study Prenat Diagn Stocker LJ Wellesley DG Stanton MP Parasuraman R Howe DT 148 153 35 2015 25256093
3 Congenital cystic adenomatoid malformation: accuracy of prenatal diagnosis, prevalence and outcome in a general population Prenat Diagn Gornall AS Budd JL Draper ES Konje JC Kurinczuk JJ 997 1002 23 2003 14663837
4 Outcome of the prenatally diagnosed congenital cystic adenomatoid lung malformation: a Canadian experience Fetal Diagn Ther Laberge JM Flageole H Pugash D 178 186 16 2001 11316935
5 Is congenital pulmonary airway malformation really a rare disease? Result of a prospective registry with universal antenatal screening program Pediatr Surg Int Lau CT Kan A Shek N Tam P Wong KK 105 108 33 2017 27770196
6 Congenital cystic adenomatoid malformation of the lung: classification and morphologic spectrum Hum Pathol Stocker JT Madewell JE Drake RM 155 171 8 1977 856714
7 Congenital cystic lung lesions: redefining the natural distribution of subtypes and assessing the risk of malignancy Am J Surg Pathol Pogoriler J Swarr D Kreiger P Adzick NS Peranteau W 47 55 43 2019 29266024
8 An assessment of the expanded classification of congenital cystic adenomatoid malformations and their relationship to malignant transformation Am J Surg Pathol MacSweeney F Papagiannopoulos K Goldstraw P Sheppard MN Corrin B Nicholson AG 1139 1146 27 2003 12883247
9 Case of mucinous adenocarcinoma of the lung associated with congenital pulmonary airway malformation in a neonate Korean J Pediatr Koh J Jung E Jang SJ Kim DK Lee BS Kim KS Kim EA 30 34 61 2018 29441110
10 Bronchioloalveolar carcinoma arising in a congenital pulmonary airway malformation in a child: case report with an update of this association J Pediatr Surg Ramos SG Barbosa GH Tavora FR Jeudy J Torres LA Tone LG Trad CS 0 4 42 2007
11 Atypical goblet cell hyperplasia occurs in CPAM 1, 2, and 3, and is a probable precursor lesion for childhood adenocarcinoma Virchows Arch Fakler F Aykutlu U Brcic L 843 854 476 2020 31858221
12 MUC5AC, cytokeratin 20 and HER2 expression and K-RAS mutations within mucinogenic growth in congenital pulmonary airway malformations Histopathology Rossi G Gasser B Sartori G 1133 1143 60 2012 22348416
13 Pulmonary invasive mucinous adenocarcinoma Histopathology Chang WC Zhang YZ Nicholson AG 18 31 84 2024 37867404
14 Mucinous cell clusters in infantile congenital pulmonary airway malformations mimic adult mucinous adenocarcinoma but are not associated with poor outcomes when appropriately resected Am J Surg Pathol Nelson ND Litzky LA Peranteau WH Pogoriler J 1118 1129 44 2020 32349050
15 Mucinous adenocarcinoma arising in congenital pulmonary airway malformation: clinicopathological analysis of 37 cases Histopathology Chang WC Zhang YZ Wolf JL 434 444 78 2021 32810914
16 Mucinous adenocarcinoma of the lung in association with congenital pulmonary airway malformation J Pediatr Surg Summers RJ Shehata BM Bleacher JC Stockwell C Rapkin L 2256 2259 45 2010 21034957
17 Prognostic impact of histopathologic features in pulmonary invasive mucinous adenocarcinomas: proposal for a pathologic grading system Am J Clin Pathol Chang WC Zhang YZ Lim E Nicholson AG 88 102 154 2020 32215558
18 The 2015 World Health Organization Classification of Lung Tumors: impact of genetic, clinical and radiologic advances since the 2004 classification J Thorac Oncol Travis WD Brambilla E Nicholson AG 1243 1260 10 2015 26291008
19 Congenital lung malformations: informing best practice Semin Pediatr Surg Baird R Puligandla PS Laberge JM 270 277 23 2014 25459011
20 Narrative review of congenital lung lesions Transl Pediatr Kunisaki SM 1418 1431 10 2021 34189102
21 Cancer cell transmission via the placenta Evol Med Public Health Greaves M Hughes W 106 115 2018 2018 29765597
22 Vaginal transmission of cancer from mothers with cervical cancer to infants N Engl J Med Arakawa A Ichikawa H Kubo T 42 50 384 2021 33406329
23 Congenital pulmonary airway malformation StatPearls [Internet] Mehta PA Sharma G Treasure Island (FL) StatPearls Publishing 2024 https://pubmed.ncbi.nlm.nih.gov/31869128/
